Results, Not Intentions: What the Healos 91-Day Protocol Actually Delivers.
Results, Not Intentions: What the Healos™ 91-Day Protocol Actually Delivers
A Different Kind of Health Promise
Most health programmes measure success by participation: did you take the supplement? The Healos™ H-Index protocol measures success by outcomes: did your cardiovascular health actually improve — across 32 measurable dimensions — over 91 documented days?
The integrative health space has a credibility problem — not because the science is weak, but because outcomes are rarely documented. Patients take supplements for months and feel "somewhat better", which is not the same as demonstrably better. The Healos™ H-Index protocol was designed to close this gap.
The Measurement Problem
The H-Index creates a personalised cardiovascular risk score that updates continuously across 32 dimensions. Every patient begins with a documented Day 0 baseline. At Day 91, the comparison is not "how do you feel?" but "here are your numbers, and here is how they changed."
32 Dimensions
The H-Index measures cardiovascular biomarkers, oxidative stress indicators, sleep quality, stress and autonomic function, nutritional status, metabolic markers, lifestyle adherence, and subjective wellbeing — simultaneously and continuously.
The Science: Three Mechanisms
Mechanism 1: H2 and Oxidative Stress Reduction
Molecular hydrogen selectively neutralises only the most harmful free radicals — hydroxyl radicals and peroxynitrite — without affecting beneficial reactive species. This selectivity, demonstrated by Ohsawa et al. in Nature Medicine (2007), makes H2 the most targeted antioxidant currently available. Alpha Hope delivers up to 11ppm H2 via Micro-Nano Bubble Technology — 7x the concentration of standard hydrogen-rich water.
Mechanism 2: PQQ and Mitochondrial Regeneration
Bio-PQQ promotes mitochondrial biogenesis — the generation of new mitochondria within existing cardiac cells — and activates SIRT3, a longevity-associated enzyme. This improves cellular energy production at the foundational level.
Mechanism 3: PGC-1α and Nrf2 Activation
H2 and PQQ taken together activate PGC-1α (the Hope Molecule — master regulator of mitochondrial biogenesis) and the Nrf2 antioxidant pathway simultaneously. This synergistic activation addresses cardiovascular risk at the regulatory level, not just the symptomatic level.
Addressing oxidative stress and mitochondrial dysfunction simultaneously — at the regulatory pathway level — is the cellular equivalent of treating the soil, not just the symptoms.
What 91 Days Looks Like
Day 0: Your Baseline
Complete the 32-dimension H-Index assessment. Receive your personalised risk score, dimension breakdown, and 91-day improvement pathway.
Days 1–30: Foundation Phase
Begin Alpha Hope protocol. AI Clawbot initiates weekly check-ins tracking your H-Index inputs. Focus: oxidative stress, sleep quality, nutritional baseline.
Days 31–60: Integration Phase
H-Index trajectory becomes visible. AI adjusts recommendations to your specific dimension patterns. Focus: mitochondrial function, metabolic markers, stress index.
Day 91: Your Outcomes Report
Full H-Index comparison: Day 91 vs Day 0 across all 32 dimensions. 80%+ of participants renew — because the data shows it is working.
Why 80%+ Renew
In the health supplement industry, average 3-month retention is 28%. The H-Index protocol achieves 80%+ renewal at 91 days because patients renew on evidence — their own H-Index data showing documented improvement — not on faith that something is working.
Retention Mechanism
Conventional supplement: 28% 3-month retention (faith-based). H-Index protocol: 80%+ 91-day renewal (evidence-based). The difference is not the product — it is the measurement.
Start With Your Own Baseline
Take the H-Index Assessment Now
Alpha Hope statements not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Consult your physician
